Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Quetiapine in Generalised Social Anxiety Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Written Confirmed Consent,~* All patients meet the DSM IV criteria for generalized social anxiety disorder,~* A score ≥ 60 on the LSAS,~* male and female aged between 18 and 65 years~Exclusion Criteria:~* Presence of any primary axis I diagnosis other than social anxiety disorder according to DSM-IV,~* alcohol and/or substance abuse according to DSM-IV criteria within the last 12 months,~* any personality disorder as the primary diagnosis, with the exception of avoidant personality disorder,~* patients at risk of suicide

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).